Cargando…

Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011

Japanese encephalitis (JE) is arguably one of the most serious viral encephalitis diseases worldwide. China has a long history of high prevalence of Japanese encephalitis, with thousands of cases reported annually and incidence rates often exceeding 15/100,000. In global terms, the scale of outbreak...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiaoyan, Li, Xiaolong, Li, Minghua, Fu, Shihong, Wang, Huanyu, Lu, Zhi, Cao, Yuxi, He, Ying, Zhu, Wuyang, Zhang, Tingting, Gould, Ernest A., Liang, Guodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133196/
https://www.ncbi.nlm.nih.gov/pubmed/25121596
http://dx.doi.org/10.1371/journal.pntd.0003015
_version_ 1782330727104249856
author Gao, Xiaoyan
Li, Xiaolong
Li, Minghua
Fu, Shihong
Wang, Huanyu
Lu, Zhi
Cao, Yuxi
He, Ying
Zhu, Wuyang
Zhang, Tingting
Gould, Ernest A.
Liang, Guodong
author_facet Gao, Xiaoyan
Li, Xiaolong
Li, Minghua
Fu, Shihong
Wang, Huanyu
Lu, Zhi
Cao, Yuxi
He, Ying
Zhu, Wuyang
Zhang, Tingting
Gould, Ernest A.
Liang, Guodong
author_sort Gao, Xiaoyan
collection PubMed
description Japanese encephalitis (JE) is arguably one of the most serious viral encephalitis diseases worldwide. China has a long history of high prevalence of Japanese encephalitis, with thousands of cases reported annually and incidence rates often exceeding 15/100,000. In global terms, the scale of outbreaks and high incidence of these pandemics has almost been unique, placing a heavy burden on the Chinese health authorities. However, the introduction of vaccines, developed in China, combined with an intensive vaccination program initiated during the 1970s, as well as other public health interventions, has dramatically decreased the incidence from 20.92/100,000 in 1971, to 0.12/100,000 in 2011. Moreover, in less readily accessible areas of China, changes to agricultural practices designed to reduce chances of mosquito bites as well as mosquito population densities have also been proven effective in reducing local JE incidence. This unprecedented public health achievement has saved many lives and provided valuable experience that could be directly applicable to the control of vector-borne diseases around the world. Here, we review and discuss strategies for promotion and expansion of vaccination programs to reduce the incidence of JE even further, for the benefit of health authorities throughout Asia and, potentially, worldwide.
format Online
Article
Text
id pubmed-4133196
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41331962014-08-19 Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011 Gao, Xiaoyan Li, Xiaolong Li, Minghua Fu, Shihong Wang, Huanyu Lu, Zhi Cao, Yuxi He, Ying Zhu, Wuyang Zhang, Tingting Gould, Ernest A. Liang, Guodong PLoS Negl Trop Dis Review Japanese encephalitis (JE) is arguably one of the most serious viral encephalitis diseases worldwide. China has a long history of high prevalence of Japanese encephalitis, with thousands of cases reported annually and incidence rates often exceeding 15/100,000. In global terms, the scale of outbreaks and high incidence of these pandemics has almost been unique, placing a heavy burden on the Chinese health authorities. However, the introduction of vaccines, developed in China, combined with an intensive vaccination program initiated during the 1970s, as well as other public health interventions, has dramatically decreased the incidence from 20.92/100,000 in 1971, to 0.12/100,000 in 2011. Moreover, in less readily accessible areas of China, changes to agricultural practices designed to reduce chances of mosquito bites as well as mosquito population densities have also been proven effective in reducing local JE incidence. This unprecedented public health achievement has saved many lives and provided valuable experience that could be directly applicable to the control of vector-borne diseases around the world. Here, we review and discuss strategies for promotion and expansion of vaccination programs to reduce the incidence of JE even further, for the benefit of health authorities throughout Asia and, potentially, worldwide. Public Library of Science 2014-08-14 /pmc/articles/PMC4133196/ /pubmed/25121596 http://dx.doi.org/10.1371/journal.pntd.0003015 Text en © 2014 Gao et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Review
Gao, Xiaoyan
Li, Xiaolong
Li, Minghua
Fu, Shihong
Wang, Huanyu
Lu, Zhi
Cao, Yuxi
He, Ying
Zhu, Wuyang
Zhang, Tingting
Gould, Ernest A.
Liang, Guodong
Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011
title Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011
title_full Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011
title_fullStr Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011
title_full_unstemmed Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011
title_short Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011
title_sort vaccine strategies for the control and prevention of japanese encephalitis in mainland china, 1951–2011
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133196/
https://www.ncbi.nlm.nih.gov/pubmed/25121596
http://dx.doi.org/10.1371/journal.pntd.0003015
work_keys_str_mv AT gaoxiaoyan vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT lixiaolong vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT liminghua vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT fushihong vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT wanghuanyu vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT luzhi vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT caoyuxi vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT heying vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT zhuwuyang vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT zhangtingting vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT gouldernesta vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011
AT liangguodong vaccinestrategiesforthecontrolandpreventionofjapaneseencephalitisinmainlandchina19512011